Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 46,700 | 94,576 | 24,371 | 16,846 | 8,820 |
| Cost of Goods | 4,599 | 7,556 | 2,291 | 1,924 | 983 |
| Gross Profit | 42,101 | 87,020 | 22,080 | 14,922 | 7,837 |
| Operating Expenses | 107,757 | 93,950 | 82,288 | 58,258 | 48,001 |
| Operating Income | -65,057 | -6,374 | -59,917 | -42,412 | -39,181 |
| Interest Expense | 2,730 | 2,264 | 1,324 | 2,411 | 2,257 |
| Pre-tax Income | -67,787 | -8,638 | -61,241 | -44,823 | -41,438 |
| Income Tax | -617 | 2,580 | N/A | N/A | N/A |
| Net Income Continuous | -67,170 | -11,218 | -61,241 | -44,823 | -41,438 |
| Net Income | $-67,170 | $-11,218 | $-61,241 | $-44,823 | $-41,438 |
| EPS Basic Total Ops | -1.54 | -0.26 | -1.44 | -1.07 | -1.06 |
| EPS Basic Continuous Ops | -1.54 | -0.26 | -1.43 | -1.07 | -1.06 |
| EPS Diluted Total Ops | -1.54 | -0.26 | -1.44 | -1.07 | -1.06 |
| EPS Diluted Continuous Ops | -1.54 | -0.26 | -1.43 | -1.07 | -1.06 |
| EPS Diluted Before Non-Recurring Items | -1.00 | -0.22 | -1.28 | -1.03 | N/A |
| EBITDA(a) | $-61,687 | $-4,128 | $-57,879 | $-40,832 | $-37,449 |